Scout Investments, Inc. Coherus Bio Sciences, Inc. Transaction History

Scout Investments, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	SELL	$3.74 - $5.45 $66,680 - $97,168	-17,829 Reduced 2.82%	614,307 $2.3 Million
Q2 2023 Aug 14, 2023	SELL	$3.79 - $8.3 $71,305 - $156,156	-18,814 Reduced 2.89%	632,136 $2.7 Million
Q1 2023 May 11, 2023	SELL	$5.89 - $10.52 $45,282 - $80,877	-7,688 Reduced 1.17%	650,950 $4.45 Million
Q4 2022 Jan 23, 2023	SELL	$5.69 - $10.07 $61,156 - $108,232	-10,748 Reduced 1.61%	658,638 $0
Q3 2022 Oct 18, 2022	SELL	$7.17 - $13.87 $135,799 - $262,697	-18,940 Reduced 2.75%	669,386 $6.43 Million
Q2 2022 Jul 15, 2022	BUY	$5.86 - $13.23 $543,450 - $1.23 Million	92,739 Added 15.57%	688,326 $4.98 Million
Q1 2022 Apr 14, 2022	SELL	$10.92 - $16.41 $8,441 - $12,684	-773 Reduced 0.13%	595,587 $7.69 Million
Q4 2021 Jan 14, 2022	SELL	$15.81 - $18.99 $211,506 - $254,048	-13,378 Reduced 2.19%	596,360 $9.52 Million
Q3 2021 Oct 13, 2021	SELL	$12.68 - $17.79 $200,737 - $281,633	-15,831 Reduced 2.53%	609,738 $9.8 Million
Q2 2021 Jul 23, 2021	BUY	$12.95 - $15.41 $966,303 - $1.15 Million	74,618 Added 13.54%	625,569 $8.65 Million
Q1 2021 Apr 09, 2021	BUY	$14.42 - $21.39 $7.94 Million - $11.8 Million	550,951 New	550,951 $8.05 Million

135

77.9M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $122M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Scout Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Scout Investments, Inc. with notifications on news.